Skip to content

Effects of Agmatine on the Occurrence of Sepsis And Related Outcomes in Severe Trauma Patients

Effects of Agmatine on the Occurrence of Sepsis And Related Outcomes in Severe Trauma Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019617
Enrollment
Unknown
Registered
2018-11-19
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Trauma

Interventions

Sponsors

State Key Laboratory of Trauma, Burns, and Combined Injury, Department 1, Research Institute of Surgery, Daping Hospital, The Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Good adherence to patients and their families with informed consents; 2. ICU Inpatients with ages between 18-65 years; 3. Admitted within 48 hours after injury and be diagnosed as severe trauma; 4. APACHE II = 15 or ISS = 16 points, the expected survival time> 7 days.

Exclusion criteria

Exclusion criteria: 1. History of any of the following: stenocardia, atrioventricular block, bronchial asthma, Peptic ulcerSevere encephalitisSevere vomiting or diarrhea, Advanced neurological disease; 2. using a monoamine oxidase inhibitor (MAOI); 3. Current treatment with medications known to interact with agmatine; 4. patients with history of substance abuse.

Design outcomes

Primary

MeasureTime frame
Incidence of sepsis;

Secondary

MeasureTime frame
Critical Illness score;health related quality of life score;hemodynamic parameters;inflammatory response;Biochemical target;

Countries

China

Contacts

Public ContactHuaping Liang

Research Institute of Surgery, Daping Hospital, Army Military Medical University

13638356728@163.com+86 13638356728

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026